Micro Labs Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Micro Labs Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7540
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Micro Labs Ltd (Micro Labs) is a healthcare service organization which conducts research and development of bio equivalent generics. The organization’s business segments include formulations and active pharmaceutical ingredients. Its products include acetamide, allercet, amiodar, amlong, amlozaar, angiplat, angizaar, and other products. Micro Labs offers products in various therapeutic areas such as analgesics and anti pyretics, anti-allergics, anti-anginals, anti-arrhythmics, anti-asthmatics and bronchodilators, anti-bacterials and others. The organization concentrates on the development of formulations in various dosage forms including solid dosage, liquid dosage, sterile preparations, injectables, creams and ointments among others. It has operations across Asia, Europe, Latin America and Africa. Micro Labs is headquartered in Bangalore, Karnataka, India.

Micro Labs Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Micro Labs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Micro Labs Rumored To Acquire Pharma Manufacturing Units In Egypt And Indonesia 10
Licensing Agreements 11
Micro Labs Enters into Licensing Agreement with Medicines Patent Pool for HIV Medicines 11
Acquisition 12
Merck Plans To Acquire Micro Labs, Maker Of Generic Drugs 12
Micro Labs Ltd – Key Competitors 13
Micro Labs Ltd – Key Employees 14
Micro Labs Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Micro Labs Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Micro Labs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Micro Labs Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Micro Labs Rumored To Acquire Pharma Manufacturing Units In Egypt And Indonesia 10
Micro Labs Enters into Licensing Agreement with Medicines Patent Pool for HIV Medicines 11
Merck Plans To Acquire Micro Labs, Maker Of Generic Drugs 12
Micro Labs Ltd, Key Competitors 13
Micro Labs Ltd, Key Employees 14
Micro Labs Ltd, Subsidiaries 15

List of Figures
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Micro Labs Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Micro Labs Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Response Biomedical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Response Biomedical Corp (Response Biomedical) focuses on the research, development, manufacture and marketing of diagnostic technologies for the point-of-care (POC), central-lab testing and on-site environmental testing markets. It offers Cardiovascular tests such as Troponin-I, Myoglobin, …
  • Carnival Corporation & Plc (CCL):企業の財務・戦略的SWOT分析
    Carnival Corporation & Plc (CCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • TAG Oil Ltd (TAO):石油・ガス:M&Aディール及び事業提携情報
    Summary TAG Oil Ltd (TAG Oil) is an oil and gas company that explores, develops and produces natural gas and crude oil across Canada. The company owns and operates oil and gas properties in Taranaki Basin and East Coast Basin. It undertakes oil and gas projects such as Boar Hill Frontier, Waitangi H …
  • Merrimack Pharmaceuticals Inc (MACK):企業の財務・戦略的SWOT分析
    Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Lilis Energy Inc (LLEX):石油・ガス:M&Aディール及び事業提携情報
    Summary Lilis Energy Inc (Lilis Energy), formerly Recovery Energy Inc is an independent oil and gas exploration and production company that acquires, explores, develops and produces oil and gas properties in the Permian's Delaware Basin. The company identifies drilling locations for multi-horizon un …
  • Petrol dd Ljubljana (PETG):企業の財務・戦略的SWOT分析
    Petrol dd Ljubljana (PETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • CIGNA Corporation:戦略・SWOT・企業財務分析
    CIGNA Corporation - Strategy, SWOT and Corporate Finance Report Summary CIGNA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • nib Holdings Limited:企業の戦略・SWOT・財務情報
    nib Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary nib Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Canadian Zinc Corp.:企業の戦略・SWOT・財務情報
    Canadian Zinc Corp. - Strategy, SWOT and Corporate Finance Report Summary Canadian Zinc Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Truman Arnold Companies, Inc.
    Truman Arnold Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Truman Arnold Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Pharma Two B Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharma Two B Ltd (Pharma Two) is a drug development company that develops and manufactures drugs for the treatment of Parkinson's disease and cancer. The company provides combination products in preclinical state and generic products including P2B 005, P2B 006, P2B 007, P2B 008 and P2B 009, …
  • Viesgo:電力:M&Aディール及び事業提携情報
    Summary Viesgo, formerly E.ON Espana SL is an energy company that generates, distributes and markets electric power and gas. The company operates coal-fired power plants, combined cycle plants, biomass plants, and hydraulic power stations. It also provides public and private charging stations for el …
  • Cenveo Worldwide Ltd:企業の戦略的SWOT分析
    Cenveo Worldwide Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Precipio Inc (TBIO):企業の財務・戦略的SWOT分析
    Summary Precipio Inc (Precipio), formerly known as Transgenomic Inc, develops diagnostic tools. The company advances personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. Precipio uses ICE COLD-P …
  • Teijin Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Teijin Pharma Ltd (Teijin Pharma), a subsidiary of Teijin Ltd develops, manufactures and markets pharmaceutical and home healthcare products. The company offers a range of pharmaceutical products for the treatment of bone and joint diseases, respiratory diseases and cardiovascular and metabo …
  • Aviva Ltd.:企業の戦略・SWOT・財務情報
    Aviva Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aviva Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Duke Energy Florida LLC:企業の戦略的SWOT分析
    Duke Energy Florida LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Morneau Shepell Inc.:企業の戦略・SWOT・財務情報
    Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report Summary Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Avisa Pharma Inc:製品パイプライン分析
    Summary Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company’s product include avisa breath test kit, which is designed to detect respiratory bacterial infections in the lung and other metabolic diseases; …
  • F. Hoffmann-La Roche Ltd:企業の戦略・SWOT・財務情報
    F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report Summary F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆